No results, please enter a search term above
|Date of Alert|
|No Health Alerts Found|
|Increase in Extensively Drug-Resistant Shigellosis in the United States||Alert||Mar 6, 2023|
|Ciprofloxacin-resistance in Shigella isolates in Philadelphia||Advisory||Apr 7, 2015|
|Increase in Community-wide Transmission of Shigella in Philadelphia||Advisory||Dec 11, 2008|
|Increase in Congenital Syphilis||Alert||Dec 2, 2008|
|Shigella Transmission Among Children in Childcare and Other Settings||Advisory||Jul 10, 2008|
No vaccines are currently available for shigellosis.
The primary way shigellosis is diagnosed is through a stool culture. Infection with Shigella bacteria can be treated with antibiotics, but these bacteria are frequently resistant to many antibiotic drugs. Providers should order antimicrobial susceptibility testing to determine the appropriate drug for treatment. Also, treatment is typically reserved for those who present with severe illness, are immunocompromised, or those who work or participate in high-risk settings (childcare, healthcare, and foodhandling).
The Philadelphia Department of Public Health regulations require the exclusion of persons with Shigella infection who participate or work in high-risk settings (e.g., childcare, foodservice, healthcare). They must have two negative stool cultures collected 24 hours apart and at least 48 hours after the completion of antiobiotic therapy before they can return.
Report shigella cases to PDPH by calling 215-685-6748 during business hours or completing this Disease reporting form and faxing the form to 215-238-6947.
There are no patient or community resources for Shigella.
There are no posters for Shigella.